MOLECULAR PARTNERS AG Quarterly Research And Development Expense in CHF from Q2 2022 to Q2 2023

Taxonomy & unit
ifrs-full: CHF
Summary
Molecular Partners Ag annual/quarterly Research And Development Expense history and growth rate from Q2 2022 to Q2 2023.
  • Molecular Partners Ag Research And Development Expense for the quarter ending June 30, 2023 was ₣11.6M, a 7.47% decline year-over-year.
  • Molecular Partners Ag annual Research And Development Expense for 2023 was ₣48.8M, a 3.87% decline from 2022.
  • Molecular Partners Ag annual Research And Development Expense for 2022 was ₣50.7M, a 8.92% decline from 2021.
  • Molecular Partners Ag annual Research And Development Expense for 2021 was ₣55.7M, a 0.64% decline from 2020.
Research And Development Expense, Quarterly (CHF)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 11.6M -939K -7.47% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-24
Q2 2022 12.6M Apr 1, 2022 Jun 30, 2022 6-K 2023-08-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.